BackAvalo Therapeutics Overview

Avalo Therapeutics Receivables

Track Avalo Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Avalo Therapeutics Receivables History

Loading

Avalo Therapeutics vs. peers: Receivables Comparison

Loading

Avalo Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Avalo Therapeutics (AVTX) FAQ

Avalo Therapeutics posts a receivables of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Avalo Therapeutics's receivables was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Avalo Therapeutics's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AVTX's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Avalo Therapeutics's other metric pages and overview cover the third.

Judging Avalo Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in receivables easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.